GENFIT Shares Higher After Hours Following Earlier Post-Market Press Release Highlighting Publication Of Results From Phase 2 Trial Of Elafibranor In Patients With Primary Biliary Cholangitis; Data Confirms Rationale Of Evaluating Compound For Phase 3

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!